Last update June 14, 2022
Likely Compatibility
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
أميسولبريد is Amisulpride in Arabic.
Is written in other languages:أميسولبريد belongs to these groups or families:
Main tradenames from several countries containing أميسولبريد in its composition:
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
It is an atypical substituted benzamide antipsychotic. It is used in the management of psychoses such as schizophrenia and also in depression. Oral administration in two daily doses or intramuscularly.
It is excreted in breast milk in a small amount, but it could become clinically significant (RD 1.8% to 11%). (OʼHalloran 2016, Teoh 2011, Ilett 2010)
No problems have been observed in infants of mothers treated with amisulpride. (Uguz 2016;23, Teoh 2011)
Possibly due to poor passage into milk and low oral bioavailability, low plasma levels were found in these infants: between 4% and 10% of the maternal serum concentration. (OʼHalloran 2016, Ilett 2010)
Like other benzamide-based substances, it may increase serum levels of Prolactin and induce galactorrhea. (Zhenhua 2022, Glocker 2021, Lee 2012, Ružić 2011, Mendhekar 2009, Raj 2008, Paparrigopoulos 2007, Bushe 2007, Kopecek 2004, Kropp 2004, Fric 2003)
Until more data on this drug is available, a safer alternative should be chosen (Uguz 2021 y 2016;36, Pacchiarotti 2016), mostly during neonatal period and with prematurity.
See below the information of these related products: